BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23510109)

  • 1. Nanomedicines for treatment of viral diseases.
    Mehendale R; Joshi M; Patravale VB
    Crit Rev Ther Drug Carrier Syst; 2013; 30(1):1-49. PubMed ID: 23510109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomedicine formulations for the delivery of antiviral drugs: a promising solution for the treatment of viral infections.
    Lembo D; Donalisio M; Civra A; Argenziano M; Cavalli R
    Expert Opin Drug Deliv; 2018 Jan; 15(1):93-114. PubMed ID: 28749739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances and challenges in nanocarriers and nanomedicines for veterinary application.
    Carvalho SG; Araujo VHS; Dos Santos AM; Duarte JL; Silvestre ALP; Fonseca-Santos B; Villanova JCO; Gremião MPD; Chorilli M
    Int J Pharm; 2020 Apr; 580():119214. PubMed ID: 32165220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology-based antiviral therapeutics.
    Chakravarty M; Vora A
    Drug Deliv Transl Res; 2021 Jun; 11(3):748-787. PubMed ID: 32748035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological voyage of solid lipid nanoparticles: a proficient carrier in nanomedicine.
    Ali H; Singh SK
    Ther Deliv; 2016 Oct; 7(10):691-709. PubMed ID: 27790956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
    Yu HP; Aljuffali IA; Fang JY
    Curr Pharm Des; 2017; 23(3):481-494. PubMed ID: 28292243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery.
    Torchilin VP
    Biopolymers; 2008; 90(5):604-10. PubMed ID: 18381624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperthermia approaches for enhanced delivery of nanomedicines to solid tumors.
    Frazier N; Ghandehari H
    Biotechnol Bioeng; 2015 Oct; 112(10):1967-83. PubMed ID: 25995079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attempts to use liposomes and RBC ghosts as vectors in drug and antisense therapy of virus infection.
    Grimaldi S; Lisi A; Pozzi D; Santoro N
    Res Virol; 1997; 148(2):177-80. PubMed ID: 9108622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicine for Cystic Fibrosis.
    Ong V; Mei V; Cao L; Lee K; Chung EJ
    SLAS Technol; 2019 Apr; 24(2):169-180. PubMed ID: 30707858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concepts on Smart Nano-Based Drug Delivery System.
    Rai S; Singh N; Bhattacharya S
    Recent Pat Nanotechnol; 2022; 16(1):67-89. PubMed ID: 33494685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What nanomedicine in the clinic right now really forms nanoparticles?
    Svenson S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2014; 6(2):125-35. PubMed ID: 24415653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedicine-based drug targeting for psoriasis: potentials and emerging trends in nanoscale pharmacotherapy.
    Rahman M; Akhter S; Ahmad J; Ahmad MZ; Beg S; Ahmad FJ
    Expert Opin Drug Deliv; 2015 Apr; 12(4):635-52. PubMed ID: 25439967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal nanomedicines.
    Fenske DB; Cullis PR
    Expert Opin Drug Deliv; 2008 Jan; 5(1):25-44. PubMed ID: 18095927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomedicine in pulmonary delivery.
    Mansour HM; Rhee YS; Wu X
    Int J Nanomedicine; 2009; 4():299-319. PubMed ID: 20054434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlling and Monitoring Intracellular Delivery of Anticancer Polymer Nanomedicines.
    Battistella C; Klok HA
    Macromol Biosci; 2017 Oct; 17(10):. PubMed ID: 28444959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomedicine as an emerging platform for metastatic lung cancer therapy.
    Landesman-Milo D; Ramishetti S; Peer D
    Cancer Metastasis Rev; 2015 Jun; 34(2):291-301. PubMed ID: 25948376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating Nanomedicines: Obstacles and Advancements.
    Swierczewska M; Crist RM; McNeil SE
    Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclodextrin-based nanosponges as vehicles for antiviral drugs: challenges and perspectives.
    Lembo D; Trotta F; Cavalli R
    Nanomedicine (Lond); 2018 Mar; 13(5):477-480. PubMed ID: 29376455
    [No Abstract]   [Full Text] [Related]  

  • 20. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.